Calico Pharmaceuticals Private Limited

Calico Pharmaceuticals Private Limited - food and beverages in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24304MH2019PTC327720 Incorporated 08 July 2019 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company food and beverages
Revenue · FY 2025
₹80.59 Lakh
▲ 183.67% YoY
Net loss · FY 2025
₹16,300
Net margin -0.2%
EBITDA · FY 2025
-₹2,300
EBITDA margin 0%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹10,000
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Calico Pharmaceuticals Private Limited

Data last updated:

Calico Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 08 July 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2019PTC327720. Its GSTIN is 27AAICC2647L1ZC (Maharashtra).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹10,000. It is led by directors Rajendra Gangaram Chavan and Rajashree Rajendra Chavan.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 04 Panchakroshi Industrial Estate Sv Road Dahisar East Sambhaji Nagar, Mumbai, Maharashtra, India – 400068.

As per the financials filed for FY 2025, the company reported a revenue of ₹80.59 Lakh. For the same year it recorded a net loss of ₹16,300 (net margin -0.2%) and EBITDA of -₹2,300 (EBITDA margin 0%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years.

Company details

CIN U24304MH2019PTC327720
Registration Number 327720
Incorporation Date 08 July 2019
ROC Mumbai
Listing Status Unlisted
Company Status Active

Contact details

Calico Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.

  • Email
  • Registered Address
    04 Panchakroshi Industrial Estate Sv Road Dahisar East Sambhaji Nagar, Mumbai, Maharashtra, India – 400068
  • Industry
    Food And Beverages, Manufacturing, Artificial Fibres

To see the full contact details of Calico Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Calico Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Calico Pharmaceuticals Private Limited

FY 2025 filings available

Calico Pharmaceuticals Private Limited reported revenue of ₹80.59 Lakh for FY 2025.

Revenue · FY 2025
₹80.59 Lakh
Net loss · FY 2025
₹16,300 margin -0.2%
EBITDA · FY 2025
-₹2,300 margin 0%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
3 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▲ 97%
3 years · compounded
▲ 88%
5 years · compounded
▲ 31%

Revenue has grown at a compounded annual rate (CAGR) of 10% over three years. EBITDA rose 97% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹2,300
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹16,300
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin0%
Net Profit Margin-0.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Calico Pharmaceuticals Private Limited, buy the company report.

Board of directors of Calico Pharmaceuticals Private Limited

Calico Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Rajendra Gangaram ChavanDirector08 Jul 20197 Years 4 MonthsCurrent
Rajashree Rajendra ChavanDirector08 Jul 20197 Years 4 MonthsCurrent

Peer comparison

Calico Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Luxuriate Pharmaceuticals Private Limited₹80.95 Lakh (FY 2015)Asansol, West Bengal, India
Aileron Pharmaceuticals Private Limited₹80.87 Lakh (FY 2025)15.0%Jaipur, Rajasthan, India
Rennova Pharmaceuticals Private Limited₹80.86 Lakh (FY 2025)-40.0%Kolhapur, Maharashtra, India
SV Well and Care Pharmaceuticals Private Limited₹80.76 Lakh (FY 2025)-18.0%Dehradun, Uttarakhand, India
Belgrand Pharmaceuticals Private Limited₹80.59 Lakh (FY 2024)21.0%Hyderabad, Telangana, India
Calico Pharmaceuticals Private Limitedthis company₹80.59 Lakh (FY 2025)-₹16,300-0.2%Mumbai, Maharashtra, India
Zeneast Pharmaceuticals Private Limited₹80.48 Lakh (FY 2024)14.0%Bhubaneswar, Odisha, India
Cypress Pharmaceuticals Private Limited₹80.44 Lakh (FY 2020)-84.0%Mumbai, Maharashtra, India
Medyur Pharmaceuticals Limited₹80.41 Lakh (FY 2025)68.0%New Delhi, Delhi, India
Altoven Pharmaceuticals Private Limited₹80.39 Lakh (FY 2024)494.0%Chennai, Tamil Nadu, India
Loyol Pharmaceuticals Private Limited₹80.32 Lakh (FY 2021)Balasore, Odisha, India

To see the full peer comparison of Calico Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Calico Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Calico Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAICC2647L1ZCMaharashtraActive03 Dec 2020

To see the full GST registrations and return filing status of Calico Pharmaceuticals Private Limited, buy the company report.

Recent activity

Calico Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Rajashree Rajendra Chavan was appointed as Director on 08 Jul 2019.

AGM
Calico Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Calico Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Rajashree Rajendra Chavan was appointed as Director.
Appointed
Rajendra Gangaram Chavan was appointed as Director.
Incorporation
08 Jul 2019
Calico Pharmaceuticals Private Limited was registered on 08 Jul 2019 with Roc Mumbai I & aged 7 years 4 months as per MCA records.

Frequently asked questions

Calico Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 08 July 2019 (7+ years old) and is registered under CIN U24304MH2019PTC327720.

Calico Pharmaceuticals has 2 current directors:

The latest financial statements of Calico Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.

The GSTIN of Calico Pharmaceuticals is 27AAICC2647L1ZC, registered in Maharashtra.

The CIN (Corporate Identification Number) of Calico Pharmaceuticals is U24304MH2019PTC327720. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Calico Pharmaceuticals was incorporated on 08 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Calico Pharmaceuticals by revenue are Luxuriate Pharmaceuticals Private Limited, Aileron Pharmaceuticals Private Limited, Rennova Pharmaceuticals Private Limited, SV Well and Care Pharmaceuticals Private Limited, Belgrand Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).

Rajashree Rajendra Chavan was appointed as Director on 08 Jul 2019. Rajendra Gangaram Chavan was appointed as Director on 08 Jul 2019.

The registered office of Calico Pharmaceuticals is at 04 Panchakroshi Industrial Estate Sv Road Dahisar East Sambhaji Nagar, Mumbai, Maharashtra, India – 400068.

Calico Pharmaceuticals operates in the food and beverages industry, in the manufacturing segment.

Calico Pharmaceuticals can be reached at its registered office: 04 Panchakroshi Industrial Estate Sv Road Dahisar East Sambhaji Nagar, Mumbai, Maharashtra, India – 400068.